Valuation: AstraZeneca PLC

Market Cap 262B 230B 213B 196B 370B 25,045B 377B 2,533B 994B 12,299B 983B 961B 42,474B P/E 2026 *
21.1x
P/E 2027 * 18.5x
Enterprise Value 281B 246B 228B 210B 397B 26,882B 405B 2,719B 1,067B 13,201B 1,055B 1,032B 45,590B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 4.1x
Free-Float
96.63%
Yield 2026 *
1.98%
Yield 2027 * 2.09%

Last Transcript: AstraZeneca PLC

1 day-0.36%
1 week-12.49%
Current month-10.85%
1 month-4.77%
3 months-15.74%
6 months-12.38%
Current year-8.85%
1 week 12,388
Extreme 12388
14,332
1 month 11,484
Extreme 11484
15,126
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Free

See Remarks

2 0.0000%
Jun. 07Free

See Remarks

1 0.0000%
May. 19Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%-12.49%+17.90%+21.76% 262B
-0.56%-1.52%+49.04%+171.88% 1,054B
+0.31%-0.60%+64.29%+62.31% 621B
-0.03%-2.65%+28.86%+85.64% 438B
-0.26%-2.86%+27.98%+21.61% 325B
-0.67%-2.54%+28.16%+45.46% 281B
-1.06%-1.94%-27.56%-39.61% 219B
-0.81%-1.63%+22.07%+58.33% 195B
+1.21%+1.38%+19.85%+71.29% 163B
+1.28%+3.20%-4.56%-32.11% 140B
Average -0.29%-1.21%+22.60%+46.66% 369.57B
Weighted average by Cap. -0.53%-1.50%+34.30%+79.18%

Financials

2026 *2027 *
Net sales 63.22B 55.45B 51.35B 47.25B 89.37B 6,051B 91.11B 612B 240B 2,971B 237B 232B 10,261B 66.8B 58.59B 54.26B 49.93B 94.44B 6,393B 96.27B 647B 254B 3,140B 251B 245B 10,843B
Net income 12.43B 10.9B 10.1B 9.29B 17.58B 1,190B 17.92B 120B 47.21B 584B 46.68B 45.66B 2,018B 13.94B 12.22B 11.32B 10.42B 19.7B 1,334B 20.09B 135B 52.92B 655B 52.33B 51.19B 2,262B
Net Debt 19.2B 16.84B 15.59B 14.35B 27.14B 1,837B 27.67B 186B 72.9B 902B 72.09B 70.51B 3,116B 11.95B 10.48B 9.7B 8.93B 16.89B 1,143B 17.22B 116B 45.36B 561B 44.85B 43.87B 1,939B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-14 GBX 12,552.00 -0.46% 607,152
26-07-13 GBX 12,610.00 -1.75% 2,741,916
26-07-10 GBX 12,834.00 -3.89% 3,355,019
26-07-09 GBX 13,354.00 -6.22% 7,624,478
26-07-08 GBX 14,240.00 -0.86% 1,480,149
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
168.70USD
Average target price
212.84USD
Spread / Average Target
+26.16%

Quarterly revenue - Rate of surprise